BOSTON SCIENTIFIC CORPORATION Most Important Performance Measures
The measures each proxy statement lists as most important for linking pay to performance (Item 402(v) tabular list), as tagged, newest proxy first.
- 2024-03-20: Measure Adjusted EPS*.
- 2024-03-20: Measure Adjusted Net Sales*.
- 2024-03-20: Measure DE&I Targets.
- 2024-03-20: Measure Employee Engagement Targets.
| Proxy filed | Measure |
|---|---|
| 2024-03-20 | Adjusted EPS* |
| 2024-03-20 | Adjusted Net Sales* |
| 2024-03-20 | DE&I Targets |
| 2024-03-20 | Employee Engagement Targets |
| 2024-03-20 | Environmental Targets |
| 2024-03-20 | Organic Net Sales Growth* |
| 2024-03-20 | Relative Total Shareholder Return |
| 2025-03-19 | Adjusted Net Sales* |
| 2025-03-19 | Adjusted EPS* |
| 2025-03-19 | Adjusted Operating Income Margin* |
| 2025-03-19 | Organic Net Sales Growth* |
| 2025-03-19 | Relative Total Shareholder Return |
| 2026-03-18 | Adjusted Net Sales* |
| 2026-03-18 | Adjusted EPS* |
| 2026-03-18 | Adjusted OIM* |
| 2026-03-18 | Organic Net Sales Growth* |
| 2026-03-18 | Relative Total Shareholder Return |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |